Abstract:Transcatheter aortic valve replacement (TAVR) has become a solid alternative to surgical aortic valve replacement (SAVR) for the treatment of severe symptomatic aortic stenosis in patients across the entire risk spectrum. [1][2][3][4][5] Although the clinical outcomes of TAVR valves have been favorable with large multicenter trials showing no inferiority, and even superiority of TAVR versus SAVR 6,7 , the lingering question about the long-term durability of TAVR valves is still unanswered. As the TAVR populati… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.